Susan E. Graf - 08 Jun 2023 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role: Director
Signature: By: /s/ Matthew P. Blischak, Attorney-in-Fact
Issuer symbol: FNCH
Transactions as of: 08 Jun 2023
Net transactions value: +$1,353
Form type: 4
Filing time: 09 Jun 2023, 16:15:17 UTC
Previous filing: 15 Jun 2022
Next filing: 24 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FNCH	Common Stock	Purchase	$1,353	+5,010		$0.2700	5,010	09 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FNCH	Stock Option (right to buy)	Award	$0	+10,000		$0.000000	10,000	08 Jun 2023	Common Stock	10,000	$0.2850	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest in twelve equal monthly installments beginning on July 8, 2023, subject to the Reporting Person continuing to provide service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney